Stored platelets alter glycerophospholipid and sphingolipid species, which are differentially transferred to newly released extracellular vesicles

Transfusion

Volumn 53, Issue 3, 2013, Pages 612-626

  Pienimaeki Roemer, Annika ^a   Ruebsaamen, Katharina ^a   Boettcher, Alfred ^a   Orsõ, Evelyn ^a   Scherer, Max ^a   Liebisch, Gerhard ^a   Kilalic, Dzenan ^a   Ahrens, Norbert ^a   Schmitz, Gerd ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN E; CERAMIDE; CHOLESTEROL; GLYCEROPHOSPHOLIPID; LYSOPHOSPHATIDIC ACID; SPHINGOLIPID; THROMBOCYTE CONCENTRATE;

ADULT; ARTICLE; BLOOD BANK; CELL TRANSFER; CELL VACUOLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID RAFT; MALE; PROTEIN EXPRESSION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; VASCULAR DISEASE;

ADULT; BIOLOGICAL TRANSPORT; BLOOD PLATELETS; BLOOD PRESERVATION; CELL AGING; EXTRACELLULAR SPACE; FEMALE; GLYCEROPHOSPHOLIPIDS; HUMANS; MALE; MIDDLE AGED; PLATELETPHERESIS; SECRETORY VESICLES; SPHINGOLIPIDS; YOUNG ADULT;

EID: 84874947105     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03775.x     Document Type: Article

References (73)

1. Michelson AD,. Platelet storage and transfusion. In:, Michelson AD, editor. Platelets. San Diego: Academic Press; 2002. p. 877-96.
2. Paglieroni TG, Janatpour K, Gosselin R, Crocker V, Dwyre DM, MacKenzie MR, Holland PV, Larkin EC,. Platelet function abnormalities in qualified whole-blood donors: effects of medication and recent food intake. Vox Sang 2004; 86: 48-53.
3. Ohto H, Nollet KE,. Overview on platelet preservation: better controls over storage lesion. Transfus Apher Sci 2011; 44: 321-5.
4. Seghatchian J, Krailadsiri P,. The platelet storage lesion. Transfus Med Rev 1997; 11: 130-44.
5. Leaver HA, Schou AC, Rizzo MT, Prowse CV,. Calcium-sensitive mitochondrial membrane potential in human platelets and intrinsic signals of cell death. Platelets 2006; 17: 368-77.
6. Bode AP,. Platelet activation may explain the storage lesion in platelet concentrates. Blood Cells 1990; 16: 109-25.
7. Wolfs JL, Comfurius P, Rasmussen JT, Keuren JF, Lindhout T, Zwaal RF, Bevers EM,. Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserine exposure in a distinct platelet fraction. Cell Mol Life Sci 2005; 62: 1514-25.
8. Taha TA, Hannun YA, Obeid LM,. Sphingosine kinase: biochemical and cellular regulation and role in disease. J Biochem Mol Biol 2006; 39: 113-31.
9. Tani M, Ito M, Igarashi Y,. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal 2007; 19: 229-37.
10. Gerrard JM, Robinson P,. Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta 1989; 1001: 282-5.
11. Yatomi Y, Ruan F, Hakomori S, Igarashi Y,. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995; 86: 193-202.
12. Siess W,. Athero- and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002; 1582: 204-15.
13. Grassmé H, Schwarz H, Gulbins E,. Molecular mechanisms of ceramide-mediated CD95 clustering. Biochem Biophys Res Commun 2001; 284: 1016-30.
14. Megha, London E,. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J Biol Chem 2004; 279: 9997-10004.
15. Babiychuk EB, Atanassoff AP, Monastyrskaya K, Brandenberger C, Studer D, Allemann C, Draeger A,. The targeting of plasmalemmal ceramide to mitochondria during apoptosis. PLoS ONE 2011; 6: e23706.
16. Scarlatti F, Bauvy C, Ventruti A, Sala G, Cluzeaud F, Vandewalle A, Ghidoni R, Codogno P,. Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1. J Biol Chem 2004; 279: 18384-91.
17. Shupik MA, Vanin AF, Alessenko AV,. Interaction of the nitric oxide signaling system with the sphingomyelin cycle and peroxidation on transmission of toxic signal of tumor necrosis factor-α in ischemia-reperfusion. Biochemistry (Mosc) 2011; 76: 1197-209.
18. Morita SY, Kawabe M, Sakurai A, Okuhira K, Vertut-Doï A, Nakano M, Handa T,. Ceramide in lipid particles enhances heparan sulfate proteoglycan and low density lipoprotein receptor-related protein-mediated uptake by macrophages. J Biol Chem 2004; 279: 24355-61.
19. Major AS, Joyce S, Van Kaer L,. Lipid metabolism, atherogenesis and CD1-restricted antigen presentation. Trends Mol Med 2006; 12: 270-8.
20. Ruebsaamen K, Liebisch G, Boettcher A, Schmitz G,. Lipidomic analysis of platelet senescence. Transfusion 2010; 50: 1665-76.
21. Horstman LL, Ahn YS,. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999; 30: 111-42.
22. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, Lindhout T, Curvers J,. Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006; 134: 307-13.
23. Nomura S, Ozaki Y, Ikeda Y,. Function and role of microparticles in various clinical settings. Thromb Res 2008; 123: 8-23.
24. Castaman G, Yu-Feng L, Battistin E, Rodeghiero F,. Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generation. Br J Haematol 1997; 96: 458-63.
25. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A,. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost 2001; 85: 810-20.
26. Liebisch G, Lieser B, Rathenberg J, Drobnik W, Schmitz G,. High-throughput quantification of phosphatidylcholine and sphingomyelin by electrospray ionization tandem mass spectrometry coupled with isotope correction algorithm. Biochim Biophys Acta 2004; 1686: 108-17.
27. Liebisch G, Drobnik W, Reil M, Truembach B, Arnecke R, Olgemoeller B, Roscher A, Schmitz G,. Quantitative measurement of different ceramide species from crude cellular extracts by electrospray ionization tandem mass spectrometry (ESI-MS/MS). J Lipid Res 1999; 40: 1539-46.
28. Liebisch G, Binder M, Schifferer R, Langmann T, Schulz B, Schmitz G,. High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochim Biophys Acta 2006; 1761: 121-8.
29. Scherer M, Leuthäuser-Jaschinski K, Ecker J, Schmitz G, Liebisch G,. A rapid and quantitative LC-MS/MS method to profile sphingolipids. J Lipid Res 2010; 51: 2001-11.
30. Scherer M, Schmitz G, Liebisch G,. High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry. Clin Chem 2009; 55: 1218-22.
31. Robert S, Poncelet P, Lacroix R, Arnaud L, Giraudo L, Hauchard A, Sampol J, Dignat-George F,. Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 2009; 7: 190-7.
32. Birõ É, Nieuwland R, Sturk A,. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1843-4.
33. Filipe V, Hawe A, Jiskoot W,. Critical evaluation of nanoparticle tracking analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates. Pharm Res 2010; 27: 796-810.
34. Bligh EG, Dyer WJ,. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-17.
35. Baker DL, Desiderio DM, Miller DD, Tolley B, Tigyi GJ,. Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. Anal Biochem 2001; 292: 287-95.
36. Bruegger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD,. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry. Proc Natl Acad Sci U S A 1997; 94: 2339-44.
37. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D,. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res 2008; 49: 1137-46.
38. Zemski Berry KA, Murphy RC,. Electrospray ionization tandem mass spectrometry of glycerophosphoethanolamine plasmalogen phospholipids. J Am Soc Mass Spectrom 2004; 15: 1499-508.
39. Matsuo H, Chevallier J, Mayran N, Le Blanc I, Ferguson C, Fauré J, Blanc NS, Matile S, Dubochet J, Sadoul R, Parton RG, Vilbois F, Gruenberg J,. Role of LBPA and Alix in multivesicular liposome formation and endosome organization. Science 2004; 303: 531-4.
40. Lässer C, Eldh M, Lötvall J,. Isolation and characterization of RNA-containing exosomes. J Vis Exp 2012; 59: e303738.
41. Voelker DR,. Phosphatidylserine translocation to the mitochondrion is an ATP-dependent process in permeabilized animal cells. Proc Natl Acad Sci U S A 1989; 86: 9921-5.
42. Verkleij AJ, Leunissen-Bijvelt B, de Kruijff M, Hope M, Cullis PR,. Non-bilayer structures in membrane fusion. Ciba Found Symp 1984; 103: 45-59.
43. Zech T, Ejsing CS, Gaus K, de Wet B, Shevchenko A, Simons K, Harder T,. Accumulation of raft lipids in T-cell plasma membrane domains engaged in TCR signalling. EMBO J 2009; 28: 466-76.
44. Bruegger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Kraeusslich HG,. The HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci U S A 2006; 103: 2641-6.
45. Birõ E, Akkerman JW, Hoek FJ, Gorter G, Pronk LM, Sturk A, Nieuwland R,. The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions. J Thromb Haemost 2005; 3: 2754-63.
46. Salzer U, Zhu R, Luten M, Isobe H, Pastushenko V, Perkmann T, Hinterdorfer P, Bosman GJ,. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008; 48: 451-62.
47. (2+)-triggered membrane fusion. J Cell Sci 2006; 119: 2688-94.
48. Nurminen TA, Holopainen JM, Zhao H, Kinnunen PK,. Observation of topical catalysis by sphingomyelinase coupled to microspheres. J Am Chem Soc 2002; 124: 12129-34.
49. Vieira CR, Munoz-Olaya JM, Sot J, Jiménez-Baranda S, Izquierdo-Useros N, Abad JL, Apellániz B, Delgado R, Martinez-Picado J, Alonso A, Casas J, Nieva JL, Fabriás G, Mañes S, Goñi FM,. Dihydrosphingomyelin impairs HIV-1 infection by rigidifying liquid-ordered membrane domains. Chem Biol 2010; 17: 766-75.
50. Barry OP, Pratico D, Lawson JA, FitzGerald GA,. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997; 99: 2118-27.
51. Thukkani AK, McHowat J, Hsu FF, Brennan ML, Hazen SL, Ford DA,. Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 2003; 108: 3128-33.
52. Ojala PJ, Hirvonen TE, Hermansson M, Somerharju P, Parkkinen J,. Acyl chain-dependent effect of lysophosphatidylcholine on human neutrophils. J Leukoc Biol 2007; 82: 1501-9.
53. Maślanka K, Smoleńska-Sym G, Michur H, Wrõbel A, Lachert E, Brojer E,. Lysophosphatidylcholines: bioactive lipids generated during storage of blood components. Arch Immunol Ther Exp (Warsz) 2012; 60: 55-60.
54. Kanzawa N, Maeda Y, Ogiso H, Murakami Y, Taguchi R, Kinoshita T,. Peroxisome dependency of alkyl-containing GPI-anchor biosynthesis in the endoplasmic reticulum. Proc Natl Acad Sci U S A 2009; 106: 17711-6.
55. Medof ME, Nagarajan S, Tykocinski ML,. Cell-surface engineering with GPI-anchored proteins. FASEB J 1996; 10: 574-86.
56. Yatomi Y, Yamamura S, Hisano N, Nakahara K, Igarashi Y, Ozaki Y,. Sphingosine 1-phosphate breakdown in platelets. J Biochem 2004; 136: 495-502.
57. Randriamboavonjy V, Badenhoop K, Schmidt H, Geisslinger G, Fisslthaler B, Fleming I,. The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes. Basic Res Cardiol 2009; 104: 333-40.
58. Nugent D, Xu Y,. Sphingosine-1-phosphate: characterization of its inhibition of platelet aggregation. Platelets 2000; 11: 226-32.
59. Scherer M, Böttcher A, Schmitz G, Liebisch G,. Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry. Biochim Biophys Acta 2011; 1811: 68-75.
60. McDermott MI, Sigal YJ, Crump JS, Morris AJ,. Enzymatic analysis of lipid phosphate phosphatases. Methods 2006; 39: 169-79.
61. Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I,. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins. J Clin Invest 1996; 98: 1455-64.
62. Huber LC, Juengel A, Distler JH, Moritz F, Gay RE, Michel BA, Pisetsky DS, Gay S, Distler O,. The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis 2007; 12: 363-74.
63. Fielding CJ, Reaven GM, Liu G, Fielding PE,. Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer. Proc Natl Acad Sci U S A 1984; 81: 2512-6.
64. Noël C, Marcel YL, Davignon J,. Plasma phospholipids in the different types of primary hyperlipoproteinemia. J Lab Clin Med 1972; 79: 611-21.
65. Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF,. The platelet microparticle proteome. J Proteome Res 2005; 4: 1516-21.
66. Tschopp J, Jenne DE, Hertig S, Preissner KT, Morgenstern H, Sapino AP, French L,. Human megakaryocytes express clusterin and package it without apolipoprotein A-1 into alpha-granules. Blood 1993; 82: 118-25.
67. Martens L, Van Damme P, Van Damme J, Staes A, Timmerman E, Ghesquière B, Thomas GR, Vandekerckhove J, Gevaert K,. The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics 2005; 5: 3193-204.
68. Escolar G, Lopez-Vilchez I, Diaz-Ricart M, White JG, Galan AM,. Internalization of tissue factor by platelets. Thromb Res 2008; 122 Suppl 1: S37-41.
69. Klinger MH,. The storage lesion of platelets: ultrastructural and functional aspects. Ann Hematol 1996; 73: 103-12. Review.
70. Jenne DE, Lowin B, Peitsch MC, Boettcher A, Schmitz G, Tschopp J,. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J Biol Chem 1991; 266: 11030-6.
71. Miyata M, Biro S, Kaieda H, Eto H, Orihara K, Kihara T, Obata H, Matsushita N, Matsuyama T, Tei C,. Apolipoprotein J/clusterin is induced in vascular smooth muscle cells after vascular injury. Circulation 2001; 104: 1407-12.
72. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF,. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101: 2285-93.
73. Beisiegel U, Weber W, Ihrke G, Herz J, Stanley KK,. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature 1989; 341: 162-4.